Synthesis and molecular docking studies of some novel Schiff bases incorporating 6-butylquinolinedione moiety as potential topoisomerase IIβ inhibitors.
Clicks: 241
ID: 100191
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
68.9
/100
235 views
190 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
A series of novel pyranoquinolinone-based Schiff's bases were designed and synthesized. They were evaluated for topoisomerase IIβ (TOP2B) inhibitory activity, and cytotoxicity against breast cancer cell line (MCF-7) for the development of novel anticancer agents. A molecular docking study was employed to investigate their binding and functional properties as TOP2B inhibitors, using the Discovery Studio 2.5 software, where they showed very interesting ability to intercalate the DNA-topoisomerase complex. Compounds , and showed high docking score values (82.36% -29.98 kcal mol for compound , 78.18% -26.98 kcal mol for compound and 78.65, -28.11 kcal mol for compound ) and revealed the highest enzyme inhibition activity. The best hit compounds exhibited highly potent TOP2B inhibitors with submicromolar IC50 at 5 µM compared to the reference doxorubicin.
| Reference Key |
hassanin2018synthesisroyal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hassanin, Hany M;Serya, Rabah A T;Abd Elmoneam, Wafaa R;Mostafa, Mai A; |
| Journal | Royal Society open science |
| Year | 2018 |
| DOI |
10.1098/rsos.172407
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.